Expression and clinical value of the plasma peroxiredoxin family in early pregnancy for predicting subsequent gestational diabetes mellitus

doi:10.4239/wjd.123635

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

(15)

(0)

(117)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Diabetes. Aug 15, 2026; 17(8): 123635
Published online Aug 15, 2026. doi: 10.4239/wjd.123635

Table 1 Comparison of normality and homogeneity of variance for plasma indicators between the control and observation group

Indicators	Group	Kolmogorov-Smirnov		Levene’s
Indicators	Group	Statistics	P value	Statistics	P value
Age (years)	Control group	0.174	0.000	32.855	0.000
Age (years)	Observation group	0.105	0.000	32.855	0.000
Height (m)	Control group	0.074	0.005	2.373	0.124
Height (m)	Observation group	0.088	0.000	2.373	0.124
Pre-pregnancy weight (kg)	Control group	0.103	0.000	15.555	0.000
Pre-pregnancy weight (kg)	Observation group	0.083	0.001	15.555	0.000
Pre-pregnancy BMI (kg/m²)	Control group	0.056	0.087	12.211	0.001
Pre-pregnancy BMI (kg/m²)	Observation group	0.058	0.069	12.211	0.001
Mid-pregnancy weight (kg)	Control group	0.093	0.000	0.854	0.356
Mid-pregnancy weight (kg)	Observation group	0.078	0.002	0.854	0.356
Mid-pregnancy BMI (kg/m²)	Control group	0.067	0.018	2.993	0.084
Mid-pregnancy BMI (kg/m²)	Observation group	0.054	0.200	2.993	0.084
Triglyceride (mmol/L)	Control group	0.101	0.000	87.157	0.000
Triglyceride (mmol/L)	Observation group	0.081	0.001	87.157
Total cholesterol (mmol/L)	Control group	0.080	0.001	0.764	0.383
Total cholesterol (mmol/L)	Observation group	0.104	0.000	0.764
HDL-C (mmol/L)	Control group	0.094	0.000	35.254	0.000
HDL-C (mmol/L)	Observation group	0.081	0.001	35.254
LDL-C (mmol/L)	Control group	0.083	0.001	216.949	0.000
LDL-C (mmol/L)	Observation group	0.074	0.005	216.949
Fasting blood glucose (mmol/L)	Control group	0.076	0.004	64.616	0.000
Fasting blood glucose (mmol/L)	Observation group	0.095	0.000	64.616
Glycated hemoglobin (%)	Control group	0.269	0.000	6.660	0.010
Glycated hemoglobin (%)	Observation group	0.113	0.000	6.660
PRDX1 (pg/mL)	Control group	0.200	0.000	34.567	0.000
PRDX1 (pg/mL)	Observation group	0.091	0.000	34.567
PRDX2 (pg/mL)	Control group	0.134	0.000	0.033	0.855
PRDX2 (pg/mL)	Observation group	0.122	0.000	0.033
PRDX3 (pg/mL)	Control group	0.060	0.047	8.873	0.003
PRDX3 (pg/mL)	Observation group	0.119	0.000	8.873
PRDX4 (pg/mL)	Control group	0.126	0.000	0.072	0.788
PRDX4 (pg/mL)	Observation group	0.086	0.000	0.072
PRDX5 (pg/mL)	Control group	0.166	0.000	17.742	0.000
PRDX5 (pg/mL)	Observation group	0.062	0.036	17.742
PRDX6 (pg/mL)	Control group	0.069	0.012	9.271	0.002
PRDX6 (pg/mL)	Observation group	0.102	0.000	9.271

BMI: Body mass index; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol; PRDX: Peroxiredoxin.

Full Size Table

Citation: Xu XP, Ding S, Che YM, Li J, Zhang Z, Qian C. Expression and clinical value of the plasma peroxiredoxin family in early pregnancy for predicting subsequent gestational diabetes mellitus. World J Diabetes 2026; 17(8): 123635
URL: https://www.wjgnet.com/1948-9358/full/v17/i8/123635.htm
DOI: https://dx.doi.org/10.4239/wjd.123635

Xu XP, Ding S, Che YM, Li J, Zhang Z, Qian C. Expression and clinical value of the plasma peroxiredoxin family in early pregnancy for predicting subsequent gestational diabetes mellitus. World J Diabetes 2026; 17(8): 123635 [DOI: 10.4239/wjd.123635]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.